Physician profile
Robert E Jackson
NPI 1184740045
$7,087.35
in general payments reported to CMS, 2019-2025
16 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,271 · 2020: $111 · 2021: $146 · 2022: $158 · 2023: $16.70 · 2024: $82.16 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,000.00 | 2019 | |
| Medtronic, INC. | $299.53 | 2021-2022 | |
| Boston Scientific Corporation | $275.60 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Astellas Pharma US INC | $162.77 | 2019-2020 | |
| Allergan, INC. | $59.16 | 2019 | |
| Ferring Pharmaceuticals INC. | $47.70 | 2019 | |
| Endo USA, INC. | $47.36 | 2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $44.67 | 2020-2025 | |
| Abbvie INC. | $30.54 | 2025 | |
| Procept Biorobotics Corporation | $30.39 | 2025 | |
| Sumitomo Pharma America, INC. | $27.41 | 2025 | Orgovyx |
| Olympus America INC. | $21.67 | 2025 | Itind System |
| Neotract INC. | $12.67 | 2020 | |
| Endo Pharmaceuticals INC. | $12.08 | 2019 | |
| Therapeuticsmd, INC. | $11.98 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.